Previous 10 | Next 10 |
home / stock / tlt / tlt articles
Wall Street started the week on a positive note, as all major U.S. indices and every sector within the S&P 500 showed gains during the morning ...
Risk aversion intensified during Friday’s morning trading, with stocks taking a sharp downturn while gold and oil rallied in the wake of heig...
Wall Street had a mixed morning session as investors carefully assessed the implications of another strong inflation report, pondering how it might...
U.S. stocks experienced a robust rally as of midday trading Tuesday in New York, with Wall Street mirroring the positive sentiment seen in Asia and...
Markets kicked off the week with heightened volatility due to the ongoing conflict between Israel and the Palestinian militant group Hamas. Israel...
The unexpected attack on Israel by Hamas may spur a shift towards gold and other safe haven assets, suggesting a potential surge in market demand. ...
Wall Street staged a robust rebound Friday, driven by a significantly stronger-than-expected labor market report that reignited investor confidence...
Risk aversion returned on Thursday as stocks retraced their gains from Wednesday. Traders are now closely monitoring the eagerly anticipated non-fa...
Risk sentiment rebounded during midday Wednesday trading in New York as stocks surged, driven by a retreat in Treasury yields after several session...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...